TrialThe Journal of clinical endocrinology and metabolism2018

Pramlintide but Not Liraglutide Suppresses Meal-Stimulated Glucagon Responses in Type 1 Diabetes.

Alfonso Galderisi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.